英文别名:
Diphosphoramide,N,N',N'',N'''-tetrakis(1-methylethyl)-;Tetraisopropyl pyrophosphoramide;(2S,5R,6R)-3,3-dimethyl-4,7-dioxo-6-[(2-phenoxyacetyl)amino]-4λ4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;ISO-OMPA;Tetra(monoisopropyl)pyrophosphortetramide iso-OMPA;Tetra(monoisopropyl)pyrophosphortetramide;HY-131922;CS-0143402;NCGC00016002-05;SR-01000076147;HMS3263N09;EU-0101184;InChI=1/C12H32N4O3P2/c1-9(2)13-20(17,14-10(3)4)19-21(18,15-11(5)6)16-12(7)8/h9-12H,1-8H3,(H2,13,14,17)(H2,15,16,18);Tetraisopropyl pyrophos-phoramide;({[bis(propan-2-ylamino)phosphoryl]oxy}(propan-2-ylamino)phosphoryl)(propan-2-yl)amine;513-00-8;NS00043577;NCGC00016002-03;N-[bis(propan-2-ylamino)phosphoryloxy-(propan-2-ylamino)phosphoryl]propan-2-amin;NCGC00094438-01;Tetraisopropylpyrophosphoramide;SR-01000076147-1;HMS2236P05;NCGC00016002-06;NCGC00016002-04;Diphosphoramide, N,N',N'',N'''-tetrakis(1-methylethyl)-;Lopac-T-1505;DTXSID00965589;Pyrophosphorotetramide, N,N',N'',N'''-tetra(isopropyl)-;NCGC00261869-01;EINECS 208-149-5;SCHEMBL6263949;N,N',N'',N'''-Tetraisopropyldiphosphoramide;SDCCGSBI-0051151.P002;NCGC00016002-01;LP01184;Lopac0_001184;N-[bis(propan-2-ylamino)phosphoryloxy-(propan-2-ylamino)phosphoryl]propan-2-amine;NCGC00016002-02;CHEMBL494887;T 1505;N-[Bis(isopropylamino)phosphoryloxy-(isopropylamino)phosphoryl]propan-2-amine;IOIMDJXKIMCMIG-UHFFFAOYSA-;AKOS016015535;SMR001230724;Tox21_501184;TETRAISOPROPYLPYROPHOSPHAMIDE;BDBM10625;N,N',N'',N -tetra-iso-Propylpyrophosphoramide;Tetraisoproryl Pyrophosphoramide;NCGC00094438-02;MLS002153308;DB-051938;Tetraisopropyl pyrophosphoramide, butyrylcholinesterase inhibitor;HMS3372B16;CHEBI:182475;CCG-205258;
Inchi:
InChI=1S/C12H32N4O3P2/c1-9(2)13-20(17,14-10(3)4)19-21(18,15-11(5)6)16-12(7)8/h9-12H,1-8H3,(H2,13,14,17)(H2,15,16,18)